Regenerative Biologics at Prestige Regenerative Medicine
At Prestige Regenerative Medicine, we are registered as Investigators with the Institute of Regenerative Education (IORE), and we are offering advanced regenerative biologics: autologous and allogenic HCT/Ps (human cells, tissues, and cellular and tissue-based products) to adults experiencing joint discomfort.
What are HCT/Ps?
HCT/Ps (human cells, tissues, and cellular and tissue-based products) is the FDA’s term for products made from human cells or tissues, like donated bone and skin grafts and corneas. Regenerative medicine is a fast-moving field, and interest in these products comes from ongoing research into how the body repairs and maintains tissue.
There are two types of HCT/Ps:
-
From you: Autologous
Your own tissue, collected and used in your own care. -
From a donor: Allogenic
Umbilical cord material donated by consenting mothers after full-term C-section births, sourced from AATB-certified U.S. laboratories.
How we approach safety
Every patient receives an individual consultation and a detailed informed consent before any procedure.
Donor tissue comes from tissue banks that screen donors through medical history review, a risk behavior assessment, and laboratory testing for infectious diseases, including hepatitis B and C and HIV. Tissue that doesn’t meet those requirements is rejected, and each product carries a lot number so it can be tracked after treatment.
Our providers are enrolled in the IORE Observational Registry, so patients who choose to participate are followed with safety and outcomes questionnaires over time.
What to expect
Before your visit: Your provider will review your history and ask you to avoid anti-inflammatory medications and supplements for a few days beforehand.
At your visit: After a thorough consent discussion, the area is cleaned and the product is applied. A topical or small local anesthetic may be used for comfort.
After your visit: You’ll get written instructions, including avoiding activities that cause heavy sweating for 72 hours. Many patients may be offered a series of visits over several weeks, which you’ll discuss with your provider.
About the IORE Observational Registry
The Real World Outcomes of HCT/Ps Observational Registry is overseen by an Institutional Review Board and led by Principal Investigator Dr. Scott M. Martin, M.D., M.S. Patients complete brief surveys to provide data for the registry. Participation is voluntary, and you may withdraw at any time without losing access to our medical care.
.png)
Meet Your Investigators
Our providers are enrolled as Independent Registry Investigators in the Real World Outcomes of HCT/Ps Observational Registry, led by Principal Investigator Dr. Scott M. Martin, M.D., M.S.
Investigators are trained on the registry’s safety and reporting standards, so patients who choose to participate are followed carefully.
Frequently asked questions
